US · Healthcare

Genenta Science SpA ADR (GNTA)

Biotechnology

Genenta Science SpA ADR (GNTA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GNTA

P/E ratio

25.00

Genenta Science SpA ADR (GNTA) — FAQ

What is GNTA's P/E ratio?

The price-to-earnings (P/E) ratio for Genenta Science SpA ADR (GNTA) is 25.00 (data as of 2026-05-23).

Does Genenta Science SpA ADR pay a dividend?

Dividend yield is not available in the current snapshot for Genenta Science SpA ADR (GNTA). Check the MyAverix Finance app for the latest dividend data.

What sector is Genenta Science SpA ADR in?

Genenta Science SpA ADR (GNTA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GNTA listed on?

GNTA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)